We hypothesize that the high EFFscore subgroup may secrete ANGPTL4 and MDK to activate myCAF populations, particularly LRRC15+ Fib and STRA6+ Fib, thereby driving late-stage ECM remodeling and promoting tumor invasion and metastasis. The gene discussed is ANGPTL4; the disease is neoplasm.